Objective:

To examine the use of claims data for monitoring hepatitis B and D indicators in Germany.

Approach:

Key Findings:

• Claims data provide insights into hepatitis B and D testing rates and infection prevalence.
• The study identified annual numbers of persons tested for HBV and HDV, prevalent and newly detected HBV infections, and prevalent HDV infections among HBV-positive individuals.

Interpretation:

Claims data may serve as a complementary source for hepatitis monitoring, but they do not capture uninsured or undiagnosed individuals.

Limitations:

• Claims data reflect only diagnosed and coded individuals with access to healthcare services.
• The study does not assess linkage to care due to lack of detailed clinical pathway information, which limits understanding of the care cascade.

Conclusion:

Claims data can provide information on hepatitis B and D epidemiology in Germany, aiding in the assessment of progress towards elimination goals.

Sources:

• InGef Research Database
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.